Monocyte-endothelial cell interactions in vascular and tissue remodeling

Front Immunol. 2023 Jul 7:14:1196033. doi: 10.3389/fimmu.2023.1196033. eCollection 2023.

Abstract

Monocytes are circulating leukocytes of innate immunity derived from the bone marrow that interact with endothelial cells under physiological or pathophysiological conditions to orchestrate inflammation, angiogenesis, or tissue remodeling. Monocytes are attracted by chemokines and specific receptors to precise areas in vessels or tissues and transdifferentiate into macrophages with tissue damage or infection. Adherent monocytes and infiltrated monocyte-derived macrophages locally release a myriad of cytokines, vasoactive agents, matrix metalloproteinases, and growth factors to induce vascular and tissue remodeling or for propagation of inflammatory responses. Infiltrated macrophages cooperate with tissue-resident macrophages during all the phases of tissue injury, repair, and regeneration. Substances released by infiltrated and resident macrophages serve not only to coordinate vessel and tissue growth but cellular interactions as well by attracting more circulating monocytes (e.g. MCP-1) and stimulating nearby endothelial cells (e.g. TNF-α) to expose monocyte adhesion molecules. Prolonged tissue accumulation and activation of infiltrated monocytes may result in alterations in extracellular matrix turnover, tissue functions, and vascular leakage. In this review, we highlight the link between interactions of infiltrating monocytes and endothelial cells to regulate vascular and tissue remodeling with a special focus on how these interactions contribute to pathophysiological conditions such as cardiovascular and chronic liver diseases.

Keywords: angiogenesis; cardiovascular diseases; endothelial cell; liver diseases.; macrophage; monocyte; tumor.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Communication
  • Cytokines / metabolism
  • Endothelial Cells*
  • Macrophages / metabolism
  • Monocytes*

Substances

  • Cytokines

Grants and funding

This work was supported by grants to PM-L. from Ministerio de Ciencia, Innovación y Universidades (Grant PID2021-123426OB-I00/funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”). PM-L. was additionally supported by a fellowship from the Ramon y Cajal Program (RYC2018-0Z23971-I) funded by the Spanish Ministerio de Ciencia e Innovación MCIN/AEI/10.13039/501100011033 and FSE invierte en tu futuro. MM-B. had a Formación de Profesorado Universitario (FPU) grant from Ministerio de Ciencia, Innovación y Universidades and FSE invierte en tu futuro (Reference: FPU19/03323). ERE. was supported by a grant (R01 GM 49039) from the National Institutes of Health. The Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) is funded by the Instituto de Salud Carlos III. RedFibro (RED2022-134485-T) of the 2022 call for aid to «RESEARCH NETWORKS», within the framework of the Programa Estatal del Plan Estatal de Investigación Científica, Técnica y de Innovación 2021–2023. Consolidated Research Group of the Generalitat de Catalunya AGAUR (2021 SGR 00881).